Abstract
Recently, a common somatic mutation, A-to-G transition at nucleotide 908, in the estrogen receptor-α (ERα) gene has been reported. This mutation causes an amino acid change in the ER hinge domain (lysine 303 to arginine, K303R) and confers an increased sensitivity to estrogen and an increased cellular proliferative potential. This mutation has been observed more frequently in breast cancers than in premalignant lesions. According to the previously published reports, the mutation was found in 62% of invasive breast cancers, 85% of the node-positive tumors, and 30% of proliferative breast hyperplasias in the study of US women. The purpose of our study was to investigate whether or not this mutation is present in breast cancers found in Japanese women. We performed mutation analysis using the genomic PCR and direct sequencing in 101 cases of breast cancer and eight cases of benign breast lesions. No K303R mutation was found in the ERα gene in these breast lesions obtained from Japanese patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J: Sequence and expression of human estrogen receptor complementary DNA. Science 231: 1150–1154, 1986
Menasce LP, White GR, Harrison CJ, Boyle JM: Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 17: 263–265, 1993
Fuqua SA, Wiltschke C, Zhang QX, Borg A, Castles CG, Friedrichs WE, Hopp T, Hilsenbeck S, Mohsin S, O'Connell P, Allred DCA: hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res 60: 4026–4029, 2000
Fuqua SA: The role of estrogen receptor alfa and beta in breast tumor progression. In: The 10th Annual Meeting of the Japanese Breast Cancer Society, Nagoya, Japan, 5-6 July 2002, pp 90–91
Fuqua SA: The role of estrogen receptors in breast cancer metastasis. J Mammary Gland Biol Neoplasia 6: 407–417, 2001
Japanese Breast Cancer Society. General Rules for Clinical and Pathological Recording of Breast Cancer, 14th edn, Tokyo, Kanehara, 2001, pp 1–18
Hill SM, Fuqua SA, Chamness GC, Greene GL, McGuire WL: Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res 49: 145–148, 1989
Watts CK, Handel ML, King RJ, Sutherland RL: Oestrogen receptor gene structure and function in breast cancer. J Steroid Biochem Mol Biol 41: 529–536, 1992
Yaich L, Dupont WD, Cavener DR, Parl FF: Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res 52: 77–83, 1992
Poola I, Clarke R, DeWitty R, Leffall LD: Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women. Cancer 94: 615–623, 2002
Zhang Z, Yamashita H, Toyama T, Omoto Y, Sugiura H, Hara Y, Haruki N, Kobayashi S, Iwase H: Estrogen receptor alpha mutation (A-to-G transition at nucleotide 908) is not found in different types of breast lesions from Japanese women. Breast Cancer 10: 70–73, 2003
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tokunaga, E., Kimura, Y. & Maehara, Y. No Hypersensitive Estrogen Receptor-α Mutation (K303R) in Japanese Breast Carcinomas. Breast Cancer Res Treat 84, 289–292 (2004). https://doi.org/10.1023/B:BREA.0000019963.67754.93
Issue Date:
DOI: https://doi.org/10.1023/B:BREA.0000019963.67754.93